AMG2504
AMG2504 is a TRPA1 antagonist with an IC50 value of 35 nM against human TRPA1. AMG2504 inhibits human TRPA1 activation induced by AITC and noxious cold stimulation. AMG2504 is applicable to research related to chronic pain.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 202342-22-1
- 分子式: C15H10Cl4N2O3S
- 分子量:440.13
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
IC50 & Target
[2]|
hTRPA 35 nM (IC50) |
体外実験
AMG2504 potently inhibits human TRPA1 with an IC50 of 35 nM. It exhibits no agonist activity against human TRPA1, and shows only extremely low or no antagonist activity against rat TRPA1[2].
AMG2504 potently inhibits AITC (HY-B1515)-induced intracellular calcium influx in CHO cells expressing human TRPA1, with an IC50 of 35 nM, and suppresses AITC-induced inward currents in cells, with an IC50 of 167 nM[3].
AMG2504 inhibits noxious cold stimulus-induced 45Ca2+ uptake in CHO cells expressing human TRPA1, with an IC50 of 105 nM[3].
AMG2504 is selective for human TRPA1, with IC50 values greater than 5 μM against human TRPV1, TRPM8, TRPV3 and TRPV4[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
化学情報
-
CAS 番号 202342-22-1
-
分子量 440.13
-
分子式 C15H10Cl4N2O3S
-
SMILES
O=C(C1=CC=C([N+]([O-])=O)C=C1)NC(C(Cl)(Cl)Cl)SC2=CC=C(C=C2)Cl
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
純度とドキュメンテーション
参考文献
[1]. Tanner MR, et al. Differences in ion channel phenotype and function between humans and animal models. Front Biosci (Landmark Ed). 2018;23(1):43-64. Published 2018 Jan 1. [Content Brief]
[2]. Eid SR. Therapeutic targeting of TRP channels--the TR(i)P to pain relief. Curr Top Med Chem. 2011;11(17):2118-30. [Content Brief]
[3]. Klionsky L, et al. Species-specific pharmacology of Trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists. Mol Pain. 2007;3:39. Published 2007 Dec 17. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)